WebMay 23, 2007 · BioNumerik Pharmaceuticals, Inc. ClinicalTrials.gov Identifier: NCT00477282 Other Study ID Numbers: KTN32313R : First Posted: May 23, 2007 Key Record Dates: Last Update Posted: March 12, 2024 Last Verified: March 2024 WebJan 21, 2010 · BioNumerik Pharmaceuticals, Inc., based in San Antonio, Texas, is focused on the discovery, development and commercialization of novel drugs for the treatment of cancer and cancer supportive care ...
Working At BioNumerik Pharmaceuticals: Employee …
WebDec 2, 2004 · BioNumerik Pharmaceuticals, Inc. ClinicalTrials.gov Identifier: NCT00097903 Other Study ID Numbers: KTN22208 : First Posted: December 2, 2004 Key Record Dates: Last Update Posted: March 12, 2024 Last Verified: March 2024 WebBioNumerik Pharmaceuticals General Information. Description. Operator of an oncology pharmaceutical company focused on discovering and developing novel pharmaceutical agents for the treatment of patients with cancer. The company offers a multi-disciplinary technology platform, which concurrently integrates chemistry, biology and quantum … how many people saw the risen jesus
Full Time jobs in Township of Fawn Creek, KS - Indeed
WebDeveloping and commercializing drugs for treating cancer BioNumerik … WebBioNumerik Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of drugs that help in the treatment … WebAug 1, 2006 · SAN ANTONIO, July 31 /PRNewswire/ -- Takeda Pharmaceutical Company Limited ("Takeda," Osaka, Japan) and BioNumerik Pharmaceuticals, Inc. ("BioNumerik", San Antonio, Texas) today announced the results of two Phase III Trials for Tavocept(TM). Tavocept is an investigational new drug with potential for oncology and non-oncology … how many people saw the world cup final